News & Events
New Clinical Site Added
Ophthalmic Sciences has initiated recruitment at Assuta Hashalom, the country’s busiest eye clinic, also marking the testing initiation of its most advanced prototype
Company Presenting at the 2022 Glaucoma 360 Event
Ophthalmic Sciences is presenting its technology and early clinical results on February 11, 2022 at the Glaucoma 360 event. Read more
Ophthalmic Sciences Secures $1.1M Financing
Signaling a vote of confidence in the company, a $1.1M subscription has been secured from existing and new investors that will help boost R&D activities. The financing is a prelude to a $2.5M post-seed round planned to close by
Leading ophthalmologist joins company as Board member
Prof. David Goldblum, MD, a renowned researcher and industry expert joins the board, bringing much value as the company enters clinical and commercial phases. Read more
IOPerfect™ clinical study gets thumbs up, recruiting starts next week
A leading hospital in Israel, Assuta Medical Center, will host the pilot study of the IOPerfect™, to include up to 400 eyes, a key company milestone. Read more
